11/12
02:41 pm
rlay
Will Relay Therapeutics (RLAY) Board Additions Signal a Shift in Commercialization Strategy? [Yahoo! Finance]
Low
Report
Will Relay Therapeutics (RLAY) Board Additions Signal a Shift in Commercialization Strategy? [Yahoo! Finance]
11/7
02:22 pm
rlay
Relay Therapeutics (NASDAQ:RLAY) had its price target raised by analysts at Wells Fargo & Company from $4.00 to $6.00. They now have an "equal weight" rating on the stock.
Low
Report
Relay Therapeutics (NASDAQ:RLAY) had its price target raised by analysts at Wells Fargo & Company from $4.00 to $6.00. They now have an "equal weight" rating on the stock.
11/6
04:40 pm
rlay
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
Low
Report
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
11/6
04:16 pm
rlay
Relay Therapeutics GAAP EPS of -$0.43 misses by $0.02 [Seeking Alpha]
Low
Report
Relay Therapeutics GAAP EPS of -$0.43 misses by $0.02 [Seeking Alpha]
11/6
04:05 pm
rlay
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
Medium
Report
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
11/3
04:05 pm
rlay
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
Low
Report
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
10/30
04:05 pm
rlay
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
Low
Report
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
9/21
09:35 am
rlay
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 [Yahoo! Finance]
Medium
Report
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 [Yahoo! Finance]
9/8
12:58 am
rlay
Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY) [Yahoo! Finance]
Low
Report
Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY) [Yahoo! Finance]